[HTML][HTML] Cholecystokinin receptor antagonist induces pancreatic stellate cell plasticity rendering the tumor microenvironment less oncogenic
G Jolly, T Duka, N Shivapurkar, W Chen, S Bansal… - Cancers, 2023 - mdpi.com
Simple Summary The tumor microenvironment of pancreatic cancer consists of dense
fibrotic stroma, which, to a certain extent, accounts for the relative drug resistance of this …
fibrotic stroma, which, to a certain extent, accounts for the relative drug resistance of this …
[HTML][HTML] Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic
G Jolly, T Duka, N Shivapurkar, W Chen, S Bansal… - Cancers, 2023 - ncbi.nlm.nih.gov
CCK receptors are expressed on pancreatic cancer epithelial cells, and blockade with
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic
G Jolly, T Duka, N Shivapurkar, W Chen, S Bansal… - Cancers, 2023 - europepmc.org
CCK receptors are expressed on pancreatic cancer epithelial cells, and blockade with
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic
G Jolly, T Duka, N Shivapurkar, W Chen, S Bansal… - …, 2023 - search.proquest.com
CCK receptors are expressed on pancreatic cancer epithelial cells, and blockade with
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic
G Jolly, T Duka, N Shivapurkar, W Chen… - …, 2023 - pubmed.ncbi.nlm.nih.gov
CCK receptors are expressed on pancreatic cancer epithelial cells, and blockade with
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
[PDF][PDF] Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic. Cancers 2023, 15 …
G Jolly, T Duka, N Shivapurkar, W Chen, S Bansal… - 2023 - researchgate.net
CCK receptors are expressed on pancreatic cancer epithelial cells, and blockade with
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic.
G Jolly, T Duka, N Shivapurkar, W Chen, S Bansal… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: The tumor microenvironment of pancreatic cancer consists of
dense fibrotic stroma, which, to a certain extent, accounts for the relative drug resistance of …
dense fibrotic stroma, which, to a certain extent, accounts for the relative drug resistance of …
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic.
G Jolly, T Duka, N Shivapurkar, W Chen, S Bansal… - Cancers, 2023 - europepmc.org
CCK receptors are expressed on pancreatic cancer epithelial cells, and blockade with
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …
receptor antagonists decreases tumor growth. Activated pancreatic stellate cells or …